Search research articles
Contact Us
Filters
Showing results (241-250 of 298) with videos related to
Page
of 30
Sort By:
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Leukemia
|
May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Current Research in Translational Medicine
|
October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT
Giorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
Blood Cancer Journal
|
September 27, 2022
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, et al.
Haematologica
|
November 5, 2017
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid, Liesbeth C de Wreede, Anja van Biezen, et al.
Blood Advances
|
October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability
Marie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
American Journal of Hematology
|
January 6, 2023
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Guillermo Ortí, Luuk Gras, Nienke Zinger, et al.
The Lancet. Haematology
|
December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.
Bone Marrow Transplantation
|
November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Kavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Blood Advances
|
January 10, 2022
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
Habib Zouali, Juliette Lemasson, Andreea Calugareanu, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 298) with videos related to
Sort By:
Page
of 30
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Leukemia
|
May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Current Research in Translational Medicine
|
October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT
Giorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
Blood Cancer Journal
|
September 27, 2022
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, et al.
Haematologica
|
November 5, 2017
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Christoph Schmid, Liesbeth C de Wreede, Anja van Biezen, et al.
Blood Advances
|
October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability
Marie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
American Journal of Hematology
|
January 6, 2023
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Guillermo Ortí, Luuk Gras, Nienke Zinger, et al.
The Lancet. Haematology
|
December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group
Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.
Bone Marrow Transplantation
|
November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Kavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Blood Advances
|
January 10, 2022
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
Habib Zouali, Juliette Lemasson, Andreea Calugareanu, et al.
Page
of 30